SentiCare Inc. has received funding for three medication-adherence studies. The firm’s new PillStation system will be tested for its effectiveness among patients with varying health issues. One study will target post-acute coronary patients. A second will be used on patients with HIV/AIDS. The third will examine patients recovering from depression, according to the firm.
http://www.senticare.com/
